How Long Does It Take for Mounjaro to Wear Off?

You've missed a few injections and hunger is back, here's what's happening

Picture this: you've been on Mounjaro for several months, appetite well controlled, and then you miss a week, then another. Suddenly the fridge feels interesting again. That's not a failure of willpower. Tirzepatide's activity tracks its concentration in your blood, and concentration halves roughly every five days. Miss two consecutive weekly doses and you're already at a quarter of your usual level.

Full clearance (the point at which the medicine is effectively gone) takes around four to five weeks from the last injection. The rate at which those effects fade isn't a cliff edge; it's a slow gradient. Gastric emptying speeds back up, GIP and GLP-1 receptor stimulation drops away, and appetite signals that were being dampened start reasserting themselves. Knowing that gradient is gradual can help you plan: if you're pausing treatment intentionally, the first couple of weeks are often the easiest, and the third and fourth are when habits matter most. The NHS tirzepatide page notes that treatment works alongside a reduced-calorie diet and increased activity for exactly this reason, the medicine supports those changes rather than replacing them.

One thing worth clearing up gently: some people assume that once a dose is injected, the effect peaks and then simply stops at the seven-day mark when the next dose is due. It doesn't work that way. The weekly dosing interval is chosen because it keeps blood levels stable within a therapeutic range, not because the medicine is spent after exactly seven days. Understanding when Mounjaro starts working helps make sense of both ends of that curve.

When the washout period is medically important

The four-to-five-week clearance window isn't just pharmacology trivia. There are specific situations where it matters practically, and your prescriber will factor it in.

Before surgery: NHS England advises telling your anaesthetist that you take tirzepatide before any surgical procedure. Because the medicine slows gastric emptying, food and liquid may remain in the stomach longer than expected, which carries aspiration risk under general anaesthesia. Some surgical teams request a pause of one or more weekly doses beforehand; the exact timing is decided by your surgical and anaesthetic team, not a fixed rule you can apply yourself.

Switching treatments: If you're moving from Mounjaro to a different weight-management medicine, or vice versa, your prescriber will want to account for the overlap window. Starting a second agent while tirzepatide is still active at meaningful levels isn't the same as starting from scratch. The full tirzepatide clearance timeline is the reference point for those conversations.

Trying to conceive: MHRA guidance advises using contraception while on GLP-1 medicines and for a washout period before trying to conceive. For tirzepatide specifically, NHS guidance notes that women using oral contraceptive pills should add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because oral absorption may be affected. If you're planning a pregnancy, the conversation with your prescriber should happen well before you stop treatment, not the day you do. Mounjaro is not recommended during pregnancy or breastfeeding.

The clinical detail behind these timelines is grounded in the medicine's pharmacokinetics, which is why specific durations are always confirmed by your prescriber rather than estimated from general guidance. See also our frequently asked questions for related queries answered by our clinical team.

Side effects: do they fade on the same schedule?

Broadly, yes. Most of the gastrointestinal effects tied to tirzepatide (nausea, looser stools, indigestion, early fullness) track declining drug levels. They're typically most noticeable when you start or step up a dose, then settle. As the medicine clears after your last injection, those effects resolve along a similar four-to-five-week curve, though most people find they've eased considerably by week two or three.

A separate question is whether any side effect needs attention before that natural resolution. Severe or persistent stomach pain that radiates to the back is a reason to seek medical help promptly, regardless of where you are in the treatment or washout cycle. In January 2026 the MHRA updated its Drug Safety Update guidance to highlight acute pancreatitis as an infrequent but potentially serious effect of GLP-1 medicines; that symptom pattern doesn't wait out the washout window.

For side effects that are unusual, persistent, or worrying you, reporting through the MHRA's Yellow Card scheme is always an option. It helps build the national picture of how these medicines behave in real-world use, and your report counts even if the link turns out not to be confirmed. If you're experiencing vision changes while on Mounjaro, that's worth discussing with a clinician promptly rather than waiting for a routine check.

Returning to treatment after a break

If you stop Mounjaro and then restart, the question of how quickly the medicine fades has a practical flip side: how long until it's working again? The answer isn't the same as your first week on the medicine. Restarting after a break of more than a few weeks typically means returning to 2.5mg to let the body readjust, even if you were established on a higher dose. The starting dose exists to settle the gut, not because a lower dose has any meaningful weight-management effect on its own.

How long it then takes to rebuild effect depends on how long the re-titration takes and individual response. Our separate page on how long Mounjaro takes to work covers that direction of the timeline. If you're thinking about restarting or adjusting your treatment, the most useful next step is a clinical conversation rather than working from fixed timelines alone. Our free consultation connects you with a GPhC-registered prescriber who can review your history and advise on the right approach for you specifically.